INNOV17 LLC has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ARAX CO LTD, SCIENCE ORGANISATION and FABRICA ESPANOLA DE PRODUCTOS QUIM Y FARMACEUTICOS S A FAES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Blinn James | 22 |
#2 | Tilley Jefferson | 22 |
#3 | Gaweco Anderson | 22 |
#4 | Palmer Samantha | 2 |
#5 | Tilley Jefferson W | 2 |
#6 | Walker John | 2 |
Publication | Filing date | Title |
---|---|---|
US2017298060A1 | Pyrrolopyridine retinoic acid receptor-related orphan receptor modulators and uses thereof | |
US2017190712A1 | Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof | |
US2016024057A1 | Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof | |
EP3172195A1 | Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof | |
WO2016014916A1 | Azaindole retinoic acid receptor-related orphan receptor modulators and uses thereof | |
EP3116504A2 | Retinoic acid receptor-related orphan receptor modulators and uses thereof | |
US2015252051A1 | Retinoic acid receptor-related orphan receptor modulators and uses thereof |